Yi Gong

2.9k total citations
58 papers, 2.2k citations indexed

About

Yi Gong is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Yi Gong has authored 58 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 12 papers in Immunology and 10 papers in Cancer Research. Recurrent topics in Yi Gong's work include Peroxisome Proliferator-Activated Receptors (8 papers), Virus-based gene therapy research (7 papers) and RNA Interference and Gene Delivery (7 papers). Yi Gong is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Virus-based gene therapy research (7 papers) and RNA Interference and Gene Delivery (7 papers). Yi Gong collaborates with scholars based in China, United States and United Kingdom. Yi Gong's co-authors include Xiaodong Han, WU Guang-hong, Jianqing Tang, Chuntao Yuan, Hamid M. Abdolmaleky, Yuan Song, Qingming Wang, Guang‐Yu Lian, Yanfang Huang and Jiang Wu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Yi Gong

55 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Gong China 27 1.2k 451 436 252 201 58 2.2k
Marcela Hermann Austria 32 1.2k 1.0× 342 0.8× 244 0.6× 159 0.6× 46 0.2× 87 3.1k
Hiromasa Tojo Japan 32 1.6k 1.3× 215 0.5× 160 0.4× 279 1.1× 237 1.2× 111 2.9k
Gregory S. Ducker United States 17 2.1k 1.7× 284 0.6× 763 1.8× 277 1.1× 35 0.2× 29 3.2k
Ian Pike United Kingdom 28 1.5k 1.2× 290 0.6× 89 0.2× 113 0.4× 758 3.8× 66 2.7k
Simone Venz Germany 23 853 0.7× 146 0.3× 200 0.5× 122 0.5× 124 0.6× 46 1.5k
Rosa Passantino Italy 19 1.5k 1.2× 184 0.4× 1.1k 2.5× 213 0.8× 43 0.2× 39 2.6k
Ana Cuadrado Spain 25 2.8k 2.3× 324 0.7× 506 1.2× 545 2.2× 24 0.1× 40 3.9k
Jason Yu United Kingdom 15 1.1k 0.9× 129 0.3× 198 0.5× 155 0.6× 133 0.7× 21 1.8k
Toshihiko Utsumi Japan 30 1.6k 1.3× 316 0.7× 169 0.4× 232 0.9× 39 0.2× 101 2.7k
Michelle Clasquin United States 11 1.5k 1.2× 101 0.2× 673 1.5× 233 0.9× 181 0.9× 18 2.1k

Countries citing papers authored by Yi Gong

Since Specialization
Citations

This map shows the geographic impact of Yi Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Gong more than expected).

Fields of papers citing papers by Yi Gong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Gong. The network helps show where Yi Gong may publish in the future.

Co-authorship network of co-authors of Yi Gong

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Gong. A scholar is included among the top collaborators of Yi Gong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Gong. Yi Gong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Hao, Xiuli Zhao, Xiao Wang, et al.. (2025). Investigation of the role and mechanism of dapagliflozin in mitigating renal injury in rats afflicted with diabetic kidney disease. Biochemical Pharmacology. 233. 116795–116795. 3 indexed citations
3.
Gong, Yi, et al.. (2024). Lycium barbarum L. Balanced intestinal flora with YAP1/FXR activation in drug-induced liver injury. International Immunopharmacology. 130. 111762–111762. 13 indexed citations
4.
Gong, Yi, et al.. (2024). Antifungal peptides from living organisms. Frontiers in Microbiology. 15. 1511461–1511461. 1 indexed citations
6.
Gong, Yi, René Kok, Martin K. Selig, et al.. (2022). Peroxisome Metabolism Contributes to PIEZO2-Mediated Mechanical Allodynia. Cells. 11(11). 1842–1842. 3 indexed citations
7.
Wu, Fei, Yi Gong, Lili Song, et al.. (2022). In vitro and in vivo wound healing-promoting activities of phosvitin-derived peptide Pt5-1c. European Journal of Pharmacology. 920. 174833–174833. 7 indexed citations
8.
Gong, Yi, et al.. (2022). Fungicidal Activity of AP10W, a Short Peptide Derived from AP-2 Complex Subunit mu-A, In Vitro and In Vivo. Biomolecules. 12(7). 965–965. 5 indexed citations
9.
Cheng, Ming, Laura Dietz, Yi Gong, et al.. (2021). Neutralizing Antibody Evasion and Transduction with Purified Extracellular Vesicle-Enveloped Adeno-Associated Virus Vectors. Human Gene Therapy. 32(23-24). 1457–1470. 24 indexed citations
10.
Weinhofer, Isabelle, Paulus Rommer, Bettina Zierfuss, et al.. (2021). Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. Nature Communications. 12(1). 1816–1816. 36 indexed citations
11.
Yue, Yuan, Hu Liao, Qiang Pu, et al.. (2020). miR-410 induces both epithelial–mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer. Signal Transduction and Targeted Therapy. 5(1). 85–85. 70 indexed citations
12.
Hanlon, Killian S., Tetyana P. Buzhdygan, Ming J. Cheng, et al.. (2019). Selection of an Efficient AAV Vector for Robust CNS Transgene Expression. Molecular Therapy — Methods & Clinical Development. 15. 320–332. 103 indexed citations
13.
Ke, Shaobo, Hu Qiu, Jiamei Chen, et al.. (2019). ALG3 contributes to the malignancy of non-small cell lung cancer and is negatively regulated by MiR-98-5p. Pathology - Research and Practice. 216(3). 152761–152761. 33 indexed citations
14.
Wang, Fei, Zhirong Zou, Yi Gong, et al.. (2017). Correlation between serum S100β protein levels and cognitive dysfunction in patients with cerebral small vessel disease: a case–control study. Bioscience Reports. 37(2). 26 indexed citations
15.
Gong, Yi, Dakai Mu, Shilpa Prabhakar, et al.. (2015). Adenoassociated Virus Serotype 9-Mediated Gene Therapy for X-Linked Adrenoleukodystrophy. Molecular Therapy. 23(5). 824–834. 50 indexed citations
16.
Papageorgis, Panagiotis, Kuang‐Hung Cheng, Sait Öztürk, et al.. (2011). Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer. Cancer Research. 71(3). 998–1008. 172 indexed citations
17.
Li, Dongmei, Qin Liu, Yi Gong, Yu‐Feng Huang, & Xiaodong Han. (2008). Cytotoxicity and oxidative stress study in cultured rat Sertoli cells with Methyl tert-butyl ether (MTBE) exposure. Reproductive Toxicology. 27(2). 170–176. 34 indexed citations
18.
Guang-hong, WU, Chuntao Yuan, Meifang Shen, et al.. (2007). Immunological and biochemical parameters in carp (Cyprinus carpio) after Qompsell feed ingredients for long-term administration. Aquaculture Research. 38(3). 246–255. 35 indexed citations
19.
Yuan, Chuntao, Dongmei Li, Wei Chen, et al.. (2007). Administration of a herbal immunoregulation mixture enhances some immune parameters in carp (Cyprinus carpio). Fish Physiology and Biochemistry. 33(2). 93–101. 57 indexed citations
20.
Zhou, Ge, Hongmei Li, Dianne L. DeCamp, et al.. (2002). 2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers. Molecular & Cellular Proteomics. 1(2). 117–123. 306 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026